WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check One):   [ ] Form 10-K  [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-Q
                [ ] Form N-SAR

                      For Period Ended: September 30, 2004

         [   ] Transition Report on Form 10-K
         [   ] Transition Report on Form 20-F
         [   ] Transition Report on Form 11-K
         [   ] Transition Report on Form 10-Q
         [   ] Transition Report on Form N-SAR

         For Transition Period Ended:  Not Applicable.
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: Not Applicable


Genemax Corp.
Full Name of Registrant

Former Name if Applicable

1681 Chestnut Street, Suite 400
Address of Principal Executive Office (Street and Number)

Vancouver, British Columbia, Canada V6J 4M6
City, State and Zip Code

PART II--RULES 12b-25 (b) AND (c) If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) | (a) The reasons described in reasonable detail in Part | III of this form could not be eliminated without | unreasonable effort or expense; | [X] | (b) The subject annual report, semi-annual report, | transition report on Form 10-K, Form 20-F, 11-K or | Form N-SAR, or portion thereof will be filed on or | before the fifteenth calendar day following the | prescribed due date; or the subject quarterly report | or transition report on Form 10-Q, or portion thereof | will be filed on or before the fifth calendar day | following the prescribed due date; and | | (c) The accountant's statement or other exhibit required | by Rule 12b-25(c) has been attached if applicable. PART III--NARRATIVE State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed period. The registrant is unable to file its annual report on Form 10-QSB for the quarter ended September 30, 2004 within the prescribed period because of delays in compiling financial information for disclosure in the 10-QSB. PART IV--OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Henry F. Schlueter, Esq. (303) 292-3883 _______________________________________________________________________ (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). [X] Yes [ ] No _______________________________________________________________________ (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? [ X ] Yes [ ] No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. The Registrant expects that its net loss for the three months ended September 30, 2004 will be reduced by $581,800 or 44.4% as compared to the three months ended September 30, 2003 as a result of reduced consulting fees - stock based, reduced office and general expenses and reduced research and development activities. Genemax Corp. ____________________________________________ (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 17, 2004 By: /s/ RONALD HANDFORD ________________________ _____________________________________ Ronald Handford Chief Executive Officer INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.